A novel EGFR inhibitor acts as potent tool for hypoxia-activated prodrug systems and exerts strong synergistic activity with VEGFR inhibition in vitro and in vivo-Reference-Cited by-同舟云学术

A novel EGFR inhibitor acts as potent tool for hypoxia-activated prodrug systems and exerts strong synergistic activity with VEGFR inhibition in vitro and in vivo

Published:2023-07 Issue: Volume:565 Page:216237
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Caban Monika,Koblmueller Bettina,Groza Diana,Schueffl Hemma H.,Terenzi Alessio,Tolios Alexander,Mohr Thomas,Mathuber Marlene,Kryeziu Kushtrim^ORCID,Jaunecker Carola,Pirker Christine,Keppler Bernhard K.,Berger Walter,Kowol Christian R.,Heffeter Petra

Funder

Austrian Science Fund

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. Resistances to EGFR tyrosine kinase inhibitors in lung cancer-how to routinely track them in a molecular pathology laboratory?;Hofman;J. Thorac. Dis.,2019

2. Application of molecular targeted therapies in the treatment of head and neck squamous cell carcinoma (Review);Kozakiewicz;Oncol. Lett.,2018

3. Head and neck squamous cell carcinoma;Johnson;Nat. Rev. Dis. Prim.,2020

4. Diagnosis and treatment of metastatic colorectal cancer: a review;Biller;JAMA,2021

5. Targeting EGFRvIII for glioblastoma multiforme;Yang;Cancer Lett.,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural Perspectives in the Development of Novel EGFR Inhibitors for the Treatment of NSCLC;Mini-Reviews in Medicinal Chemistry;2024-10

2. Elevating the discourse on drug delivery: A fresh perspective on the utilization of coordination chemistry-driven metal-drug conjugates;Coordination Chemistry Reviews;2024-10

3. SMEK1 promotes clear cell renal cell carcinoma progression via EGFR tyrosine-kinase dependent pathway;Cancer Letters;2024-10

4. Cobalt(III)-py2en systems as potential carriers of β-ketoester-based ligands;Journal of Inorganic Biochemistry;2023-11